Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells

Journal of Virology

Volumn 72, Issue 7, 1998, Pages 5552-5558

  Wang, Xi ^a   Kenyon, William J ^a   Li, Qingxue ^a,c   Müllberg, Jürgen ^b,d   Hutt Fletcher, Lindsey M ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b AMGEN INC   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d Section of Pathobiology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN GP 42; HLA ANTIGEN CLASS 2; THROMBOSPONDIN; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; BINDING SITE; CELL INTERACTION; CELL SURFACE; CELL TRANSFORMATION; COMPLEX FORMATION; EPITHELIUM CELL; EPSTEIN BARR VIRUS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRION; VIRUS INFECTION; VIRUS RECOMBINANT;

EID: 0031801093     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.7.5552-5558.1998     Document Type: Article

References (39)

1. Borza, C., and L. M. Hutt-Fletcher. Unpublished data.
2. Dolyniuk, M., R. Pritchett, and E. Kieff. 1976. Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virus. J. Virol. 17:935-949.
3. Duus, K. M., C. Hatfield, and C. Grose. 1995. Cell surface expression and fusion by the varicella-zoster virus gH:gL glycoprotein complex: analysis by laser scanning confocal microscopy. Virology 210:429-440.
4. Fanslow, W. C., D. M. Anderson, K. H. Grabstein, E. A. Clark, D. Cosman, and R. J. Armitage. 1992. Soluble forms of CD40 inhibit biologic responses of human B cells. J. Immunol. 149:655-660.
5. Forghani, B., L. Ni, and C. Grose. 1994. Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein complex. Virology 199:458-462.
6. Fuller, A. O., R. E. Santos, and P. G. Spear. 1989. Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration. J. Virol. 63:3435-3443.
7. Gayle, M. A., J. E. Sims, S. K. Dower, and J. L. Slack. 1994. Monoclonal antibody 1994-01 (also known as ALVA 42) reported to recognize type II IL-1 receptor is specific for HLA-DR alpha and beta chains. Cyrokine 6: 83-86.
8. Gompels, U. A., and A. Minson. 1986. The properties and sequence of glycoprotein H of herpes simplex type 1. Virology 153:230-247.
9. Haddad, R. S., and L. M. Hutt-Fletcher. 1989. Depletion of virosomes made with Epstein-Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells. J. Virol. 63:4998-5005.
10. Heston, L., M. Rabson, N. Brown, and G. Miller. 1982. New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma. Nature 295:160-163.
11. Hutchinson, L., H. Browne, V. Wargent, N. Davis-Poynter, S. Primorac, K. Goldsmith, A. C. Minson, and D. C. Johnson. 1992. A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. J. Virol. 66:2240-2250.
12. Hutt-Fletcher, L. M., N. Balachandran, and P. A. LeBlanc. 1986. Modification of Epstein-Barr virus replication by tunicamycin. J. Virol. 57:117-123.
13. Kaye, J. F., U. A. Compels, and A. C. Minson. 1992. Glycoprotein H of human cytomegalovirus (HCMV) forms a stable complex with the HCMV UL115 gene product. J. Gen. Virol. 73:2693-2698.
14. Keller, P. M., A. J. Davison, R. S. Lowe, M. W. Riemen, and R. W. Ellis. 1987. Identification and sequence of the gene encoding gpIII, a major glycoprotein of varicella-zoster virus. Virology 157:526-533.
15. Knox, P. G., and L. S. Young. 1995. Epstein-Barr virus infection of CR2-transfected epithelial cells reveals the presence of MHC class II on the virion. Virology 213:147-157.
16. Lampson, L. A., and R. Levy. 1980. Two populations of Ia-like molecules on a human B cell line. J. Immunol. 125:293-299.
17. Li, Q. X., M. K. Spriggs, S. Kovats, S. M. Turk, M. R. Comeau, B. Nepom, and L. M. Hutt-Fletcher. 1997. Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J. Virol. 71:4657-4662.
18. Li, Q. X., S. M. Turk, and L. M. Hutt-Fletcher. 1995. The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells. J. Virol. 69:3987-3994.
19. Li, Q. X., L. S. Young, G. Niedobitek, C. W. Dawson, M. Birkenbach, F. Wang, and A. B. Rickinson. 1992. Epstein-Barr virus infection and replication in a human epithelial system. Nature 356:347-350.
20. Liu, D. X., U. A. Gompels, L. Foa-Tomasi, and G. Campadelli-Fiumi. 1993. Human herpesvirus 6 glycoprotein H and L homologues are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies. Virology 197:12-22.
21. Liu, D. X., U. A. Compels, J. Nicholas, and C. Lelliott. 1993. Identification and expression of the human herpesvirus 6 glycoprotein H and interaction with an accessory 40K glycoprotein. J. Gen. Virol. 74:1847-1857.
22. Miller, N., and L. M. Hutt-Fletcher. 1988. A monoclonal antibody to glycoprotein gp85 inhibits fusion but not attachment of Epstein-Barr virus. J. Virol. 62:2366-2372.
23. Nemerow, G. R., and N. R. Cooper. 1981. Isolation of Epstein-Barr virus and studies of its neutralization by human IgG and complement. J. Immunol. 127:272-278.
24. Oba, D. E., and L. M. Hutt-Fletcher. 1988. Induction of antibodies to the Epstein-Barr virus glycoprotein gp85 with a synthetic peptide corresponding to a sequence in the BXLF2 open reading frame. J. Virol. 62:1108-1114.
25. Peeters, B., N. Dewind, R. Broer, A. Gielkins, and R. Moormann. 1992. Glycoprotein H of pseudorabies virus is essential for entry and cell-to-cell spread of the virus. J. Virol. 66:3888-3892.
26. Rasmussen, L., S. R. Resta, and T. C. Merigan. 1991. Human cytomegalovirus glycoprotein-receptor interactions. Transplant. Proc. 23:60-63.
27. Rickinson, A. B., and E. Kieff. 1996. Epstein-Barr virus, p. 2397-2446. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 2. Raven Press, New York, N.Y.
28. Roop, C., L. Hutchison, and D. C. Johnson. 1993. A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells and its particles lack glycoprotein H. J. Virol. 67:2285-2297.
29. Spaete, R. R., K. Perot, P. I. Scott, J. A. Nelson, M. F. Stinski, and C. Pachl. 1993. Co-expression of truncated human cytomegalovirus gH with the UL115 gene product or the truncated human fibroblast growth factor receptor results in transport of gH to the cell surface. Virology 193:853-861.
30. Spriggs, M. K., R. J. Armitage, M. R. Comeau, L. Strockbine, T. Farrah, B. MacDuff, D. Ulrich, M. R. Alderson, J. Müllberg, and J. I. Cohen. 1996. The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DRβ chain and inhibits antigen presentation. J. Virol. 70:5557-5563.
31. Spriggs, M. K., and M. R. Comeau. Unpublished data.
32. Strnad, B. C., T. Schuster, R. Klein, R. F. Hopkins III, T. Witmer, R. H. Neubauer, and H. Rabin. 1982. Production and characterization of monoclonal antibodies against the Epstein-Barr virus membrane antigen. J. Virol. 41:258-264.
33. Takada, K. 1984. Cross-linking of cell surface immunoglobulin induces Epstein-Barr virus in Burkitt lymphoma lines. Int. J. Cancer 33:27-32.
34. Thorley-Lawson, D. A., E. M. Miyashita, and G. Khan. 1996. Epstein-Barr virus and the B cell: that's all it takes. Trends Microbiol. 4:204-208.
35. Van Vooris, W. C., R. M. Steinman, L. S. Hair, J. Luban, M. D. Witmer, S. Koide, and Z. Cohn. 1983. Specific anti-mononuclear antibodies. Application to the purification of dendritic cells and the tissue localization of macrophages. J. Exp. Med. 158:126-145.
36. Wang, X., and L. M. Hutt-Fletcher. 1998. Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect. J. Virol. 72:158-163.
37. Yao, Z., W. C. Fanslow, M. F. Seldin, A. M. Rousseau, S. L. Painter, M. R. Comeau, J. I. Cohen, and M. K. Spriggs. 1995. Herpesvirus Saimiri encodes a new cytokine, IL17, which binds to a novel cytokine receptor. Immunity 3: 811-821.
38. Yaswen, L. R., E. B. Stephens, L. C. Davenport, and L. M. Hutt-Fletcher. 1993. Epstein-Barr virus glycoprotein gp85 associates with the BKRF2 gene product and is incompletely processed as a recombinant protein. Virology 195:387-396.
39. Yoshiyama, H., S. Imai, N. Shimizu, and K. Takada. 1997. Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J. Virol. 71:5688-5691.